FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Shea Brian J.		 2. Date of Event Requiring Statement (MM/DD/YYYY)
6/6/2023 

 3. Issuer Name and Ticker or Trading Symbol

Oncorus, Inc. [ONCR]
(Last)        (First)        (Middle)

C/O ONCORUS, INC., 4 CORPORATE DRIVE		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Interim CEO /
(Street)

ANDOVER, MA 01810      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 8541 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)  (1)9/1/2031 Common Stock 15000 $10.16 D  
Employee Stock Option (right to buy)  (2)3/1/2032 Common Stock 3744 $2.00 D  
Employee Stock Option (right to buy)  (3)5/13/2032 Common Stock 14700 $1.25 D  
Employee Stock Option (right to buy)  (4)3/1/2033 Common Stock 19100 $0.39 D  
Explanation of Responses:
(1) Twenty-five percent (25%) of the shares subject to the option vested on September 1, 2022, with one thirty-sixth (1/36th) of the remaining shares subject to the option vesting each month thereafter, subject to the Reporting Person's continued service through each such vesting date.
(2) Twenty-five percent (25%) of the shares subject to the option vested on March 1, 2023, with one thirty-sixth (1/36th) of the remaining shares subject to the option vesting each month thereafter, subject to the Reporting Person's continued service through each such vesting date.
(3) Twenty-five percent (25%) of the shares subject to the option vested on December 31, 2022, twenty-five percent (25%) of the shares subject to the option shall vest on December 31, 2023, and the remaining fifty percent (50%) shall vest on December 31, 2024, subject to the Reporting Person's continued service through each such vesting date.
(4) Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2024, with one thirty-sixth (1/36th) of the remaining shares subject to the option vesting each month thereafter, subject to the Reporting Person's continued service through each such vesting date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Shea Brian J.
C/O ONCORUS, INC.
4 CORPORATE DRIVE
ANDOVER, MA 01810

Interim CEO
Signatures
/s/ Brian J. Shea6/16/2023
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Oncorus Charts.
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Oncorus Charts.